Latest Breaking News On - Director robert james wills - Page 1 : comparemela.com

StockNews com Begins Coverage on Oncternal Therapeutics (NASDAQ:ONCT)

Research analysts at StockNews.com initiated coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Get Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the stock. Separately, HC Wainwright dropped their target price on shares of Oncternal Therapeutics from $28.00 to $19.00 and set a […]

Oncternal therapeutics company profileSecurities exchange commissionOncternal therapeutics incPasadena private wealthOncternal therapeuticsGet free reportDirector robert james willsExchange commissionPrivate wealthFree reportOrphan receptorOncternal therapeutics daily

Oncternal Therapeutics (NASDAQ:ONCT) Research Coverage Started at StockNews com

StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Sunday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright reduced their price objective on Oncternal Therapeutics from $28.00 to $19.00 and set a buy rating on the stock in a research note […]

Pasadena private wealthQuantum private wealthOncternal therapeutics incSecurities exchange commissionRichmond brothers incOncternal therapeuticsFree reportGet free reportDirector robert james willsExchange commissionPrivate wealthOrphan receptorOncternal therapeutics daily

Oncternal Therapeutics (NASDAQ:ONCT) Receives New Coverage from Analysts at StockNews com

StockNews.com assumed coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Friday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright cut their target price on shares of Oncternal Therapeutics from $30.00 to $28.00 and set a buy rating on the stock in a […]

Exchange commissionRichmond brothers incSecurities exchange commissionOncternal therapeutics incOncternal therapeuticsFree reportGet free reportDirector robert james willsOrphan receptorOncternal therapeutics dailyNasdaq onctInitiated coverageStocknews com

Oncternal Therapeutics (ONCT) Scheduled to Post Quarterly Earnings on Thursday

Oncternal Therapeutics (ONCT) Scheduled to Post Quarterly Earnings on Thursday
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Oncternal therapeutics incOncternal therapeuticsGet free reportDirector robert james willsOrphan receptorOncternal therapeutics daily

Oncternal Therapeutics (NASDAQ:ONCT) Earns Hold Rating from Analysts at StockNews com

Oncternal Therapeutics (NASDAQ:ONCT) Earns Hold Rating from Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Oncternal therapeutics company profileRichmond brothers incSecurities exchange commissionOncternal therapeutics incOncternal therapeuticsFree reportGet free reportDirector robert james willsExchange commissionOrphan receptorOncternal therapeutics daily